5th Cytokine-Based Drug Development Summit 2024
Evvnt Promotion / evvnt
21.05.2024 - 23.05.2024 Wyndham Boston Beacon Hill, 5 Blossom Street, 02114 Boston, Massachusetts, USA
Time: 9:00 AM - 4:25 PM
Temi della conferenza
While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.
While leading cytokine therapeutic developers are using next-generation cytokine engineering technologies to tackle enduring efficacy and toxicity challenges to take their molecules through the clinic, the field is also looking to novel targets, novel cytokines and an expanded disease focus.
Professional congress organizer (PCO)
Hanson Wade
Hanson Wade
Annotazioni
URL:
Brochure: https://go.evvnt.com/2140304-3?pid=4832
Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, Bertolt Kreft, Chief Scientific Officer, Bright Peak Therapeutics, and more
URL:
Brochure: https://go.evvnt.com/2140304-3?pid=4832
Speakers: Aaron Meyer, Assistant Professor, UCLA, Audrey Le Floc’h, Associate Director, Regeneron, Bertolt Kreft, Chief Scientific Officer, Bright Peak Therapeutics, and more
Informazioni ed Iscrizioni:
https://go.evvnt.com/2140304-2?pid=4832
Mr. Hanson Wade
Oncologia
Contatto organizzatori
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Noi, Going International, siamo un’azienda che si è scelta come obiettivo di rendere acessibile la formazione a una grandissima quantità di persone, oltrepassanddo i confini geografici e sociali."
